Final Overall Survival and Molecular Analysis in IMmotion151, a Phase 3 Trial Comparing Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell Carcinoma

Robert J Motzer, Thomas Powles, Michael B Atkins, Bernard Escudier, David F McDermott, Boris Y Alekseev, Jae-Lyun Lee, Cristina Suarez, Daniil Stroyakovskiy, Ugo De Giorgi, Frede Donskov, Begoña Mellado, Romain Banchereau, Habib Hamidi, Omara Khan, Veronica Craine, Mahrukh Huseni, Nick Flinn, Sarita Dubey, Brian I Rini

JAMA Oncology, 22 Febb. 1

Abstract link